“Anebulo continues to make progress towards becoming the first company to have an approved treatment for ACI. During my brief tenure at Anebulo, I have been profoundly impressed with the team and their expertise in the field of cannabis overdose. I have also had the opportunity to speak with key subject matter experts and key opinion leaders, who have shared their growing enthusiasm for the work we are doing in this area of unmet need,” commented Richie Cunningham, Chief Executive Officer of Anebulo.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ANEB:
- ANEB Upcoming Earnings Report: What to Expect?
- Anebulo Pharmaceuticals names Richie Cunningham CEO
- Enphase Energy upgraded, Brighthouse downgraded: Wall Street’s top analyst calls
- Maxim starts Anebulo at Buy on acute cannabis intoxication opportunity
- Anebulo Pharmaceuticals initiated with a Buy at Maxim
